The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

Drugs such as Actonel, Boniva, and Fosamax may increase the risk of contracting esophageal cancer, according to a new study published today in the British Medical Journal. The bone drugs belong to a particular class of drugs known as bisphosphonates and have been in the news before due to adverse effects such as bone loss and jaw necrosis. A few years ago, Fosamax lawsuits were filed due to the drug’s association with jaw necrosis.

According to WebMD, there have been 34 cases of esophageal cancer linked with bisphosphonate drugs reported to the FDA.

Comments are closed.

Of Interest